Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Int J Cancer. 2011 Aug 24;130(11):2672–2684. doi: 10.1002/ijc.26269

Table 2.

Cost-effectiveness results for pre-adolescent girls.*

Kenya Mozambique Tanzania Uganda

I$/YLS I$/YLS I$/YLS I$/YLS
Adolescent vaccination followed by a single lifetime HPV DNA testing at age 35 (1-visit)
Cost per vaccinated girl: I$5 (I$0.55 per dose)
Vaccine 160 80 CS 20
Screening with HPV, age 35 § § § §
Vaccine + screening with HPV, age 35 2090 1260 740 1000
Cost per vaccinated girl: I$10 (I$2.00 per dose)
Vaccine 470 250 90 130
Screening with HPV, age 35 § § § §
Vaccine + screening with HPV, age 35 2090 1260 740 1000
Cost per vaccinated girl: I$25 (I$5.00 per dose)
Screening with HPV, age 35 1400 § § §
Vaccine 1440 750 440 490
Vaccine + screening with HPV, age 35 2090 1260 740 1000
Cost per vaccinated girl: I$50 (I$12.25 per dose)
Screening with HPV, age 35 1400 770 450 570
Vaccine § § § §
Vaccine + screening with HPV, age 35 3580 1870 1260 1300
Cost per vaccinated girl: I$200 (I$54.25 per dose)
Screening with HPV, age 35 1400 770 450 570
Vaccine § § § §
Vaccine + screening with HPV, age 35 15,000 7850 5610 5610
Adolescent vaccination followed by a single lifetime HPV DNA testing at age 35 (2-visit)
Cost per vaccinated girl: I$5 (I$0.55 per dose)
Vaccine 160 80 CS 20
Screening with HPV, age 35 § § § §
Vaccine + screening with HPV, age 35 2810 1690 1060 1370
Cost per vaccinated girl: I$10 (I$2.00 per dose)
Vaccine 470 250 90 130
Screening with HPV, age 35 § § § §
Vaccine + screening with HPV, age 35 2810 1690 1060 1370
Cost per vaccinated girl: I$25 (I$5.00 per dose)
Screening with HPV, age 35 § § § §
Vaccine 1420 750 440 490
Vaccine + screening with HPV, age 35 2810 1690 1060 1370
Cost per vaccinated girl: I$50 (I$12.25 per dose)
Screening with HPV, age 35 1860 1010 630 770
Vaccine § § § 1240
Vaccine + screening with HPV, age 35 3480 1830 1220 1370
Cost per vaccinated girl: I$200 (I$54.25 per dose)
Screening with HPV, age 35 1860 1010 630 770
Vaccine § § § §
Vaccine + screening with HPV, age 35 14,570 7650 5420 5450
*

YLS = years of life saved; HPV = human papillomavirus DNA testing; CS = cost-saving. All currencies are reported in 2005 international dollars (I$).

Gross domestic product (GDP) per capita, 2005 I$ for each country is as follows: Kenya (I$1470); Mozambique (I$791); Tanzania (I$1167); Uganda (I$1077).28

Analyses assume either 1-visit HPV testing or 2-visit HPV testing. The results should be interpreted assuming that a country has already decided to utilize a 1-visit or 2-visit strategy. Analyses that rely on alternative assumptions are provided in the Appendix.

§

These strategies are either more costly and less effective, or have higher incremental cost-effectiveness ratios than more effective options, and are thus considered dominated.